Generate a comprehensive and actionable clinical summary paragraph for Patient 6364cb60-b9c4-e73a-2d30-8e01ae1fe2e2 Pfeffer420 Matt836 male 1962-03-11 384 Boyer Street Suite 46 Independence MO 64133. Summarize in a one A4 page length report patient's medical history, treatment course, and include relevant clinical information, advice, and a clear course of action. Ensure the summary is concise yet informative, enabling doctors to effectively engage with the patient and guide their ongoing care given this data information: Condition Risk activity involvement (finding) Diagnosis Report History and physical note 1979-04-29 23:17:54+10:00 Condition Received certificate of high school equivalency (finding) Condition Full-time employment (finding) Condition Social isolation (finding) Condition Stress (finding) Diagnosis Report History and physical note 1980-05-04 23:17:54+10:00 Condition Limited social contact (finding) Diagnosis Report History and physical note 1993-05-23 23:17:54+10:00 Condition Stress (finding) Diagnosis Report History and physical note 1999-05-30 23:17:54+10:00 Condition Sepsis (disorder) Condition Septic shock (disorder) Condition Acute respiratory distress syndrome (disorder) Diagnosis Report History and physical note 2000-02-24 00:17:54+11:00 Condition Body mass index 30+ - obesity (finding) Diagnosis Report History and physical note 2002-03-18 00:17:54+11:00 Condition Stress (finding) Diagnosis Report History and physical note 2004-03-22 00:17:54+11:00 Condition Full-time employment (finding) Diagnosis Report History and physical note 2006-03-27 00:17:54+11:00 Condition Hyperlipidemia Diagnosis Report History and physical note 2008-03-31 00:17:54+11:00 Diagnosis Report History and physical note 2008-04-20 23:17:54+10:00 Diagnosis Report History and physical note 2009-04-20 23:17:54+10:00 Diagnosis Report History and physical note 2010-04-20 23:17:54+10:00 Diagnosis Report History and physical note 2011-04-20 23:17:54+10:00 Diagnosis Report History and physical note 2012-04-19 23:17:54+10:00 Condition Full-time employment (finding) Condition Victim of intimate partner abuse (finding) Diagnosis Report History and physical note 2013-03-18 00:17:54+11:00 Diagnosis Report History and physical note 2013-04-19 23:17:54+10:00 Condition Medication review due (situation) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 68 mm[Hg] 92 mm[Hg] Observation final Heart rate 62 /min Observation final Respiratory rate 13 /min Observation final Leukocytes [#/volume] in Blood by Automated count 4.165 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 5.0051 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 13.308 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 36.93 % Observation final MCV [Entitic volume] by Automated count 85.496 fL Observation final MCH [Entitic mass] by Automated count 31.291 pg Observation final MCHC [Mass/volume] by Automated count 35.89 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 42.44 fL Observation final Platelets [#/volume] in Blood by Automated count 216.46 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 339.26 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 10.984 fL Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 {score} Observation final Total score [AUDIT-C] 3 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2014-03-24T00:17:54+11:00 Diagnosis Report CBC panel - Blood by Automated count 2014-03-24 00:17:54+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2014-03-24 01:51:53+11:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2014-03-24 02:28:33+11:00 Diagnosis Report History and physical note 2014-03-24 00:17:54+11:00 Observation final Glucose [Mass/volume] in Blood 92.35 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 8.51 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.2049 mg/dL Observation final Calcium [Mass/volume] in Blood 8.84 mg/dL Observation final Sodium [Moles/volume] in Blood 137.9 mmol/L Observation final Potassium [Moles/volume] in Blood 4.42 mmol/L Observation final Chloride [Moles/volume] in Blood 102.45 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 28.71 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 88.469 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.6547 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.4933 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.4658 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.54843 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 39.422 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 59.261 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 14.519 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 188.84 mg/dL Observation final Triglycerides 133.63 mg/dL Observation final Low Density Lipoprotein Cholesterol 143.35 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 52.681 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2014-04-19 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2014-04-19 23:17:54+10:00 Diagnosis Report History and physical note 2014-04-19 23:17:54+10:00 Condition Laceration - injury (disorder) Condition Laceration of hand Diagnosis Report History and physical note 2014-05-27 23:58:51+10:00 Condition Stress (finding) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 66 mm[Hg] 102 mm[Hg] Observation final Heart rate 75 /min Observation final Respiratory rate 15 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 259.45 mg/dL Observation final Triglycerides 134.96 mg/dL Observation final Low Density Lipoprotein Cholesterol 199.64 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 32.81 mg/dL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Observation final Total score [AUDIT-C] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2015-03-30T00:17:54+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2015-03-30 00:17:54+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2015-03-30 01:31:44+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2015-03-30 02:07:02+11:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2015-03-30 02:45:20+11:00 Diagnosis Report History and physical note 2015-03-30 00:17:54+11:00 Observation final Glucose [Mass/volume] in Blood 65.04 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 7.49 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.702 mg/dL Observation final Calcium [Mass/volume] in Blood 8.51 mg/dL Observation final Sodium [Moles/volume] in Blood 143.16 mmol/L Observation final Potassium [Moles/volume] in Blood 4.81 mmol/L Observation final Chloride [Moles/volume] in Blood 101.45 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 22.44 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 75.392 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.6759 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.328 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.4946 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 1.1568 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 54.425 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22.013 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31.627 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 207.51 mg/dL Observation final Triglycerides 196.02 mg/dL Observation final Low Density Lipoprotein Cholesterol 92.04 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 78.431 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2015-04-19 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2015-04-19 23:17:54+10:00 Diagnosis Report History and physical note 2015-04-19 23:17:54+10:00 Condition Medication review due (situation) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 73 mm[Hg] 97 mm[Hg] Observation final Heart rate 68 /min Observation final Respiratory rate 13 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 4 {score} Observation final Total score [HARK] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2016-04-03T23:17:54+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2016-04-04 00:20:15+10:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2016-04-04 00:54:41+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2016-04-04 01:33:51+10:00 Diagnosis Report History and physical note 2016-04-03 23:17:54+10:00 Observation final Glucose [Mass/volume] in Blood 77.41 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 18.63 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.1647 mg/dL Observation final Calcium [Mass/volume] in Blood 10.06 mg/dL Observation final Sodium [Moles/volume] in Blood 143.09 mmol/L Observation final Potassium [Moles/volume] in Blood 5.2 mmol/L Observation final Chloride [Moles/volume] in Blood 106.67 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 24.37 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 72.288 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.5541 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.0896 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.8851 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.49701 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 44.213 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26.941 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 10.102 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 155.4 mg/dL Observation final Triglycerides 131.77 mg/dL Observation final Low Density Lipoprotein Cholesterol 83.673 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 31.436 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2016-04-18 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2016-04-18 23:17:54+10:00 Diagnosis Report History and physical note 2016-04-18 23:17:54+10:00 Diagnosis Report History and physical note 2017-03-19 00:43:06+11:00 Condition Medication review due (situation) Condition Part-time employment (finding) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 71 mm[Hg] 99 mm[Hg] Observation final Heart rate 64 /min Observation final Respiratory rate 13 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 0 {score} Observation final Total score [AUDIT-C] 0 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2017-04-09T23:17:54+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2017-04-10 00:19:10+10:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2017-04-10 00:52:57+10:00 Diagnosis Report History and physical note 2017-04-09 23:17:54+10:00 Observation final Glucose [Mass/volume] in Blood 83.92 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 16.3 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.285 mg/dL Observation final Calcium [Mass/volume] in Blood 9.08 mg/dL Observation final Sodium [Moles/volume] in Blood 143.23 mmol/L Observation final Potassium [Moles/volume] in Blood 4.2 mmol/L Observation final Chloride [Moles/volume] in Blood 109.18 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 24.51 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 76.019 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.2417 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.1114 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.1954 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.88034 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 130.59 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 58.352 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26.003 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 194.15 mg/dL Observation final Triglycerides 148.12 mg/dL Observation final Low Density Lipoprotein Cholesterol 127.79 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 75.311 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2017-04-18 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2017-04-18 23:17:54+10:00 Diagnosis Report History and physical note 2017-04-18 23:17:54+10:00 Condition Full-time employment (finding) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 63 mm[Hg] 99 mm[Hg] Observation final Heart rate 93 /min Observation final Respiratory rate 13 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 245.11 mg/dL Observation final Triglycerides 132.5 mg/dL Observation final Low Density Lipoprotein Cholesterol 192.86 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 25.75 mg/dL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 1 {score} Observation final Total score [HARK] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2018-04-15T23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2018-04-15 23:17:54+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2018-04-16 00:21:57+10:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2018-04-16 00:53:05+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2018-04-16 01:29:21+10:00 Diagnosis Report History and physical note 2018-04-15 23:17:54+10:00 Observation final Glucose [Mass/volume] in Blood 68.86 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 10.2 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.196 mg/dL Observation final Calcium [Mass/volume] in Blood 9.31 mg/dL Observation final Sodium [Moles/volume] in Blood 137.14 mmol/L Observation final Potassium [Moles/volume] in Blood 4.76 mmol/L Observation final Chloride [Moles/volume] in Blood 103.4 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 22.94 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 70.698 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.7502 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.0525 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.118 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.13922 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 71.176 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 57.384 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 9.5781 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 186.31 mg/dL Observation final Triglycerides 185.92 mg/dL Observation final Low Density Lipoprotein Cholesterol 134.15 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 55.954 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2018-04-18 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2018-04-18 23:17:54+10:00 Diagnosis Report History and physical note 2018-04-18 23:17:54+10:00 Condition Medication review due (situation) Condition Part-time employment (finding) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 70 mm[Hg] 104 mm[Hg] Observation final Heart rate 97 /min Observation final Respiratory rate 12 /min Observation final Leukocytes [#/volume] in Blood by Automated count 6.3541 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 5.4383 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 13.065 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 45.516 % Observation final MCV [Entitic volume] by Automated count 91.469 fL Observation final MCH [Entitic mass] by Automated count 30.538 pg Observation final MCHC [Mass/volume] by Automated count 35.478 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 40.464 fL Observation final Platelets [#/volume] in Blood by Automated count 233.13 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 261.87 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 10.178 fL Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Observation final Total score [DAST-10] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2019-04-21T23:17:54+10:00 Diagnosis Report CBC panel - Blood by Automated count 2019-04-21 23:17:54+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2019-04-22 00:47:00+10:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2019-04-22 01:24:23+10:00 Diagnosis Report History and physical note 2019-04-21 23:17:54+10:00 Observation final Glucose [Mass/volume] in Blood 83.01 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 14.68 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.9141 mg/dL Observation final Calcium [Mass/volume] in Blood 8.6 mg/dL Observation final Sodium [Moles/volume] in Blood 136.89 mmol/L Observation final Potassium [Moles/volume] in Blood 3.81 mmol/L Observation final Chloride [Moles/volume] in Blood 107.05 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 27.08 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 83.948 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.3839 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.0566 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.3874 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.71755 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 137.03 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 47.64 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 23.788 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 156.57 mg/dL Observation final Triglycerides 190.2 mg/dL Observation final Low Density Lipoprotein Cholesterol 126.23 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 47.599 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2019-04-28 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2019-04-28 23:17:54+10:00 Diagnosis Report History and physical note 2019-04-28 23:17:54+10:00 Condition Medication review due (situation) Condition Full-time employment (finding) Condition Limited social contact (finding) Condition Stress (finding) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 70 mm[Hg] 104 mm[Hg] Observation final Heart rate 85 /min Observation final Respiratory rate 15 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 1 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Observation final Total score [AUDIT-C] 3 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2020-04-26T23:17:54+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2020-04-27 00:19:40+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2020-04-27 00:58:52+10:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2020-04-27 01:30:28+10:00 Diagnosis Report History and physical note 2020-04-26 23:17:54+10:00 Observation final Glucose [Mass/volume] in Blood 69.22 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 11.75 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.9788 mg/dL Observation final Calcium [Mass/volume] in Blood 8.99 mg/dL Observation final Sodium [Moles/volume] in Blood 137.35 mmol/L Observation final Potassium [Moles/volume] in Blood 3.87 mmol/L Observation final Chloride [Moles/volume] in Blood 106.97 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 20.28 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 86.829 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.7599 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.6401 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.0078 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.92733 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 64.954 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 23.891 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 13.318 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 204.53 mg/dL Observation final Triglycerides 140.41 mg/dL Observation final Low Density Lipoprotein Cholesterol 127.85 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 70.457 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2020-04-27 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2020-04-27 23:17:54+10:00 Diagnosis Report History and physical note 2020-04-27 23:17:54+10:00 Condition Acute viral pharyngitis (disorder) Observation final Body temperature 37.58 Cel Diagnosis Report History and physical note 2021-02-18 18:17:54+11:00 Condition Medication review due (situation) Condition Ischemic heart disease (disorder) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 61 mm[Hg] 99 mm[Hg] Observation final Heart rate 82 /min Observation final Respiratory rate 15 /min Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 3 {score} Observation final Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 23 {score} Observation final Total score [AUDIT-C] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2021-03-01T00:17:54+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2021-03-01 01:43:47+11:00 Diagnosis Report PHQ-9 quick depression assessment panel [Reported.PHQ] 2021-03-01 02:11:34+11:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2021-03-01 02:49:08+11:00 Diagnosis Report History and physical note 2021-03-01 00:17:54+11:00 Diagnosis Report History and physical note 2021-03-08 00:17:54+11:00 Condition Abnormal findings diagnostic imaging heart+coronary circulat (finding) Diagnosis Report History and physical note 2021-03-08 07:36:49+11:00 Diagnosis Report History and physical note 2021-03-11 03:33:08+11:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose 2021-04-11T23:17:54+10:00 Diagnosis Report History and physical note 2021-04-11 23:17:54+10:00 Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 4 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 62 mm[Hg] 85 mm[Hg] Observation final Heart rate 92 /min Observation final Respiratory rate 12 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 284.1 mg/dL Observation final Triglycerides 148.55 mg/dL Observation final Low Density Lipoprotein Cholesterol 219.86 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 34.53 mg/dL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 4 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 {score} Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2021-05-02 23:17:54+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2021-05-03 00:15:53+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2021-05-03 00:54:13+10:00 Diagnosis Report History and physical note 2021-05-02 23:17:54+10:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose 2021-05-09T23:17:54+10:00 Diagnosis Report History and physical note 2021-05-09 23:17:54+10:00 Observation final Glucose [Mass/volume] in Blood 92.43 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 15.86 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.5011 mg/dL Observation final Calcium [Mass/volume] in Blood 8.87 mg/dL Observation final Sodium [Moles/volume] in Blood 137.41 mmol/L Observation final Potassium [Moles/volume] in Blood 5.17 mmol/L Observation final Chloride [Moles/volume] in Blood 105.59 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 28.17 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 65.734 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.7798 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.2398 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.0682 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 1.0747 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 31.966 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 52.069 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 19.955 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 159.48 mg/dL Observation final Triglycerides 196.92 mg/dL Observation final Low Density Lipoprotein Cholesterol 126.56 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 37.433 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2021-05-09 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2021-05-09 23:17:54+10:00 Diagnosis Report History and physical note 2021-05-09 23:17:54+10:00 Diagnosis Report History and physical note 2022-03-19 01:25:22+11:00 Condition Limited social contact (finding) Condition Stress (finding) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 62 mm[Hg] 87 mm[Hg] Observation final Heart rate 78 /min Observation final Respiratory rate 15 /min Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2022-05-08T23:17:54+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2022-05-09 00:31:35+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2022-05-09 01:15:20+10:00 Diagnosis Report History and physical note 2022-05-08 23:17:54+10:00 Observation final Glucose [Mass/volume] in Blood 64.33 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 9.48 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.7482 mg/dL Observation final Calcium [Mass/volume] in Blood 10.02 mg/dL Observation final Sodium [Moles/volume] in Blood 136.97 mmol/L Observation final Potassium [Moles/volume] in Blood 5.15 mmol/L Observation final Chloride [Moles/volume] in Blood 106.82 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 27.16 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 68.609 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.6231 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.392 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.3431 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.31966 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 137.09 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31.136 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 6.5195 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 166.87 mg/dL Observation final Triglycerides 174.5 mg/dL Observation final Low Density Lipoprotein Cholesterol 113.72 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 77.271 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2022-05-09 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2022-05-09 23:17:54+10:00 Diagnosis Report History and physical note 2022-05-09 23:17:54+10:00 Condition Medication review due (situation) Observation final Body Height 171.3 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 88.3 kg Observation final Body mass index (BMI) [Ratio] 30.09 kg/m2 Observation final Blood pressure panel with all children optional 58 mm[Hg] 81 mm[Hg] Observation final Heart rate 63 /min Observation final Respiratory rate 13 /min Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2023-05-14T23:17:54+10:00 Immunization completed Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed 2023-05-14T23:17:54+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2023-05-15 00:36:59+10:00 Diagnosis Report History and physical note 2023-05-14 23:17:54+10:00 Observation final Glucose [Mass/volume] in Blood 90.71 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 11.18 mg/dL Observation final Creatinine [Mass/volume] in Blood 3.19 mg/dL Observation final Calcium [Mass/volume] in Blood 9.23 mg/dL Observation final Sodium [Moles/volume] in Blood 138.1 mmol/L Observation final Potassium [Moles/volume] in Blood 4.87 mmol/L Observation final Chloride [Moles/volume] in Blood 103.46 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 20.56 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 75.475 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.0267 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 4.2061 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.1445 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 1.1107 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 92.838 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 36.54 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33.167 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 155.12 mg/dL Observation final Triglycerides 188.8 mg/dL Observation final Low Density Lipoprotein Cholesterol 117.78 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 31.024 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2023-05-21 23:17:54+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2023-05-21 23:17:54+10:00 Diagnosis Report History and physical note 2023-05-21 23:17:54+10:00